Skip to content
healthcare.dev

IBSRELA

NDC 73154-050, tenapanor hydrochloride, tablet, from Ardelyx, Inc..

Product NDC
73154-050
Status
Listed
Labeler
Ardelyx, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA211801
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/73154-050 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TENAPANOR HYDROCHLORIDE53.2 mg/1

Pharmacologic classes

Organic Anion Transporting Polypeptide 2B1 Inhibitors [MoA]; Sodium-Hydrogen Exchanger 3 Inhibitor [EPC]; Sodium-Hydrogen Exchanger 3 Inhibitors [MoA]

Package NDCNDC-11Package
73154-050-06731540050066 TABLET in 1 BOTTLE (73154-050-06)
73154-050-607315400506060 TABLET in 1 BOTTLE (73154-050-60)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/2102da5f-a1a0-4ac7-a1f6-38698cf7273a
  • NADAC price for package 73154005060

    GET /v1/drugs/nadac/73154005060

Use it

Look up 73154-050 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/73154-050 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 73154-050. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.